Slovenia - Antihypertensive Medicine Use
Since 2014, Slovenia Antihypertensive Medicine Use remained stable. In 2019, the country was number 4 comparing other countries in Antihypertensive Medicine Use at 14.9 Units (Defined Daily Dosage) Per Thousand Persons Per Day. Slovenia is overtaken by Slovakia, which was ranked number 3 with 20.1 Units (Defined Daily Dosage) Per Thousand Persons Per Day and is followed by Latvia with 13.5 Units (Defined Daily Dosage) Per Thousand Persons Per Day. Hungary lead the ranking with 34.8 Units (Defined Daily Dosage) Per Thousand Persons Per Day in 2019, that is an increase of 4.2% versus 2018. Canada witnessed the best average annual growth at +10.3% per year, while Slovakia witnessed the worst performance at -9.8% per year.
Loading...
| Date | Units (Defined Daily Dosage) Per Thousand Persons Per Day |
|---|---|
| 2019 | 14.90 |
| 2018 | 14.80 |
| 2017 | 15.00 |
| 2016 | 14.90 |
| 2015 | 14.80 |
How does Slovenia rank in Antihypertensive Medicine Use?
| # | 28 Countries | Units (Defined Daily Dosage) Per Thousand Persons Per Day | Last | YoY | 5‑years CAGR | |
|---|---|---|---|---|---|---|
| 1 |
#1
Hungary
|
35 | 2019 | +4.2 % | +4.2 % | View data |
| 2 |
#2
Lithuania
|
24 | 2019 | +4.7 % | -3.6 % | View data |
| 3 |
#3
Slovakia
|
20 | 2019 | +1.5 % | -9.8 % | View data |
| 4 |
#4
Slovenia
|
15 | 2019 | +0.7 % | +0.0 % | View data |
| 5 |
#5
Latvia
|
14 | 2019 | +12.5 % | +7.7 % | View data |